IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i5p2637-d757626.html
   My bibliography  Save this article

The Prevalence of Polypharmacy and Potentially Inappropriate Medications and Its Relationship with Cognitive Status in Portuguese Institutionalized Older Adults: A Cross-Sectional Study

Author

Listed:
  • Catarina Caçador

    (Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal)

  • Edite Teixeira-Lemos

    (ESAV, Polytechnic Institute of Viseu, 3500-606 Viseu, Portugal
    CERNAS-IPV Research Centre, Polytechnic Institute of Viseu, 3504-510 Viseu, Portugal)

  • Jorge Oliveira

    (ESAV, Polytechnic Institute of Viseu, 3500-606 Viseu, Portugal
    CERNAS-IPV Research Centre, Polytechnic Institute of Viseu, 3504-510 Viseu, Portugal)

  • João Pinheiro

    (Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal)

  • Luís Teixeira-Lemos

    (Nuclear Medicine Department, Centro Hospitalar e Universitário de Coimbra (CHUC), 3004-561 Coimbra, Portugal)

  • Fernando Ramos

    (Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
    REQUIMTE/LAQV, R. D. Manuel II, Apartado, 55142 Oporto, Portugal)

Abstract

The aim of this study was to evaluate the prevalence of polypharmacy and potentially inappropriate medications (PIMs) in a population of older adults living in nursing homes. Furthermore, we also intended to assess the possible association between polypharmacy, potentially inappropriate medications and cognitive impairment in institutionalized older adults. A cross-sectional study analyzed data from 193 nursing home residents in the district of Viseu, Portugal, between September 2018 and June 2019, with a mean age of 82.4 ± 6.2 years (ranging from 65 to 95 years old); 72.5% ( n = 140) were female participants. Major polypharmacy was presented in 80.8% of the study population, who took 7.6 ± 3.3 drugs per day. Using the Beers Criteria, we found that 79.3% took PIMs. There was a positive association between polypharmacy and PIM ( p < 0.001), showing that higher medicines intake increased the number of PIMs. Polypharmacy was not associated with the functionality of the older adults to perform activities of daily living, but was associated with cognitive impairment. The older adults with lower scores on the Mini Mental State Examination (MMSE) took more drugs ( p = 0.039) and used more PIM ( p < 0.001). Moreover, patients taking five or more prescription drugs per day (major polypharmacy) consuming any psychiatric, gastrointestinal or oral antidiabetic agents (regardless of whether they were considered potentially inappropriate or not) had higher odds of displaying cognitive impairment than those who did not ( p < 0.05). Older adult residents of the studied nursing homes were potentially affected by polypharmacy and inappropriate polypharmacy. This observation reveals the need to adopt and implement strategies that make drug therapy more adequate and safer for older adults.

Suggested Citation

  • Catarina Caçador & Edite Teixeira-Lemos & Jorge Oliveira & João Pinheiro & Luís Teixeira-Lemos & Fernando Ramos, 2022. "The Prevalence of Polypharmacy and Potentially Inappropriate Medications and Its Relationship with Cognitive Status in Portuguese Institutionalized Older Adults: A Cross-Sectional Study," IJERPH, MDPI, vol. 19(5), pages 1-13, February.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:5:p:2637-:d:757626
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/5/2637/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/5/2637/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Cathal A. Cadogan & Cristín Ryan & Carmel M. Hughes, 2016. "Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many," Drug Safety, Springer, vol. 39(2), pages 109-116, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Dirk Heider & Herbert Matschinger & Andreas D Meid & Renate Quinzler & Jürgen-Bernhard Adler & Christian Günster & Walter E Haefeli & Hans-Helmut König, 2018. "The impact of potentially inappropriate medication on the development of health care costs and its moderation by the number of prescribed substances. Results of a retrospective matched cohort study," PLOS ONE, Public Library of Science, vol. 13(7), pages 1-12, July.
    2. Marina Lleal & Marisa Baré & Sara Ortonobes & Daniel Sevilla-Sánchez & Rosa Jordana & Susana Herranz & Maria Queralt Gorgas & Mariona Espaulella-Ferrer & Marta Arellano & Marta de Antonio & Gloria Jul, 2022. "Comprehensive Multimorbidity Patterns in Older Patients Are Associated with Quality Indicators of Medication—MoPIM Cohort Study," IJERPH, MDPI, vol. 19(23), pages 1-16, November.
    3. Eun-Hae Lee & Ju-Ok Park & Joon-Pil Cho & Choung-Ah Lee, 2021. "Prioritising Risk Factors for Prescription Drug Overdose among Older Adults in South Korea: A Multi-Method Study," IJERPH, MDPI, vol. 18(11), pages 1-11, June.
    4. Derek Stewart & Kathrine Gibson-Smith & Katie MacLure & Alpana Mair & Albert Alonso & Carles Codina & Antonio Cittadini & Fernando Fernandez-Llimos & Glenda Fleming & Dimitra Gennimata & Ulrika Gilles, 2017. "A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people," PLOS ONE, Public Library of Science, vol. 12(11), pages 1-17, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:5:p:2637-:d:757626. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.